Navigation Links
Lupus Nephritis-Pipeline Insights, 2014
Date:9/3/2014

by Route of Administration
- Lupus Nephritis Assessment by Stage and Route of Administration
- Lupus Nephritis Assessment by Molecule Type
- Lupus Nephritis Assessment by Stage and Molecule Type
- Lupus Nephritis Therapeutics – Discontinued Products
- Lupus Nephritis Therapeutics – Dormant Products
- Products under Development by Companies, 2014

List of Figures

- Number of Products under Development for Lupus Nephritis, 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Lupus Nephritis Assessment by Monotherapy Products
- Lupus Nephritis Assessment by Combination Products
- Lupus Nephritis Assessment by Route of Administration
- Lupus Nephritis Assessment by Stage and Route of Administration
- Lupus Nephritis Assessment by Molecule Type
- Lupus Nephritis Assessment by Stage and Molecule Type

To order this report: Lupus Nephritis-Pipeline Insights, 2014
http://www.reportlinker.com/p02278638/-Lupus-Nephritis-Pipeline-Insights-2014.html

_________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001


'/>"/>
SOURCE Reportlinker
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. The Systemic Lupus Erythematosus Market Will Grow Dramatically Over the Next Decade, Increasing from Approximately $900 Million in 2012 to $4 Billion in 2022
2. New ALR-LRI Collaboration to Accelerate New Treatments for Lupus
3. Rheumatologists in the EU5 Give the Highest Satisfaction and Performance Ratings to Rituxan and Benlysta for the Treatment of Systemic Lupus Erythematosus (SLE)
4. Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis
5. Lupus Foundation of Florida Applauds Support for Biosimilars Legislation
6. For the Treatment of Lupus, the Emerging Therapies Epratuzumab and Lupuzor Have the Potential to Offer Improvements Over IV Belimumab in Reducing Disease Activity
7. Two Of The Nations Top Specialists In Lupus, Drs. Swamy Venuturupalli & Daniel Wallace, Join In Expanding Research On Auto-Immune Diseases
8. Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
9. Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
10. Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit
11. Anthera Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015  Amgen (NASDAQ: AMGN ) will present ... a.m. ET on Thursday, May 7, 2015, at the InterContinental ... , executive vice president of Global Commercial Operations at Amgen, ... can be accessed from the Events Calendar on Amgen,s website, ... will also be available on Amgen,s website for 90 days ...
(Date:5/4/2015)... DALLAS , May 4, 2015   The ... new injection, Kybella, from internationally acclaimed plastic surgeon, ... Food and Drug Administration, is proven to reduce fat ... http://photos.prnewswire.com/prnh/20150504/213559 The active ingredient in ... and gives plastic surgeons the ability to reshape this ...
(Date:5/4/2015)... Mass. and TORONTO , ... www.generex.com ) (OTCQB:GNBT) today announced that it intends to ... it receives upon completion of a definitive licensing agreement ... Smoofi, Inc. ( www.smoofi.com ) (OTCQB:SMFI). As ... non-binding letter of intent in respect of the licensing ...
Breaking Medicine Technology:Amgen To Present At The Deutsche Bank 40th Annual Healthcare Conference 2Dr. Rod Rohrich Provides Medical Expertise on Kybella 2Dr. Rod Rohrich Provides Medical Expertise on Kybella 3Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 2Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 3Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 4Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 5
... a useful and focused trial that builds on the ... best possible care for diabetic patients with chronic stable ... Society for Cardiovascular Angiography and Interventions (SCAI) encourages healthcare ... to their patients, as studied in this trial. ...
... TRIANGLE PARK, N.C., and NEW ORLEANS, June 7 New ... 69th Scientific Sessions in New Orleans show that the investigational ... levels and provided weight loss across weekly, biweekly and monthly ... managing type 2 diabetes, a disease that affects over 250 ...
Cached Medicine Technology:SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine 2SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine 3SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine 4Study Shows GSK's Novel Diabetes Treatment SYNCRIA(R) (albiglutide) Improves Glucose Control and Reduces Weight 2Study Shows GSK's Novel Diabetes Treatment SYNCRIA(R) (albiglutide) Improves Glucose Control and Reduces Weight 3
(Date:5/4/2015)... and Seattle, WA (PRWEB) May 04, 2015 ... formation of a collaboration to facilitate development of NM108, ... ophthalmic disorders that lead to blindness, including Diabetic Retinopathy. ... MiDROPS™ formulation platform developed by EyeCRO, which can deliver ... via a topical eyedrop. , Under the terms ...
(Date:5/4/2015)... Charlottesville, VA (PRWEB) May 04, 2015 Ticket ... tickets at the John Paul Jones Arena in Charlottesville, ... in the history of the music business and this beloved ... down. Paul McCartney, the former member of two legendary groups: ... decades in the music business since 2013 on the “Out ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 New findings ... Brain Tumor Association (ABTA) show that people diagnosed with ... and treatment options, including clinical trials, at the time ... to make difficult decisions about their course of treatment. ... of the first nationwide brain tumor volunteer network, the ...
(Date:5/4/2015)... Pricing Healthcare announces it will ... patient receiving care at St. George Surgical Center ... be performed by July 15th, 2015, and the patient must ... front and forego the filing of insurance claims). , The ... year, and it devastates more and more individuals and families. ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Sheltering Arms ... Center from Hale House. The Mother Hale Learning Center ... affordable Early Childhood Education. Sheltering Arms will begin operating ... to be served by the center. , Opened in ... ages six weeks to five years, many of whom ...
Breaking Medicine News(10 mins):Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3Health News:Sheltering Arms Acquires the Mother Hale Learning Center 2
... code for a type of pancreatic cancer, called neuroendocrine or ... 20 issue of Science Express, shows that patients ... as those without them. "One of the most significant ... of rare cancer has a unique genetic code that predicts ...
... Researchers from Upstate New York institutions, including the ... two industrial pollutants in carp in eastern Lake ... demonstrating the lasting environmental effects of human activity ... The two contaminants the scientists studied were polychlorinated ...
... in an 8-week mindfulness meditation program appears to make ... of self, empathy and stress. In a study ... Psychiatry Research: Neuroimaging, a team led by ... their study, the first to document meditation-produced changes over ...
... , FRIDAY, Jan. 21 (HealthDay News) -- Americans suffering from ... in a cream to help soothe their aches. But ... on: analgesics delivered through a medicated patch placed directly where ... the country,s first over-the-counter, pain-relieving transdermal patches in 2008. But ...
... Department of Psychiatry at Case Western Reserve University School of ... National Institute of Mental Health (NIMH) for the long-term study ... the NIMH, one of the National Institutes of Health (NIH), ... in which 707 children between the ages of six and ...
... HealthDay Reporter , THURSDAY, Jan. 20 (HealthDay News) -- ... think vaccines don,t cause autism, a new Harris Interactive/HealthDay ... vaccines, like the measles-mumps-rubella (MMR) vaccine, can cause the disorder, ... conducted last week, following news reports that said the lead ...
Cached Medicine News:Health News:Johns Hopkins scientists crack genetic code for form of pancreatic cancer 2Health News:Johns Hopkins scientists crack genetic code for form of pancreatic cancer 3Health News:Scientists find industrial pollutants in Eastern Lake Erie carp 2Health News:Scientists find industrial pollutants in Eastern Lake Erie carp 3Health News:Mindfulness meditation training changes brain structure in 8 weeks 2Health News:Mindfulness meditation training changes brain structure in 8 weeks 3Health News:Pain Patches Making Gains in U.S. 2Health News:Case Western Reserve receives $7.8M to study manic symptoms in children 2Health News:Case Western Reserve receives $7.8M to study manic symptoms in children 3Health News:Nearly Half of Americans Still Suspect Vaccine-Autism Link 2Health News:Nearly Half of Americans Still Suspect Vaccine-Autism Link 3
Prostate biopsy transducer....
Multi-frequency, HST, linear transducer with a longer (60mm) footprint. Available with puncture adapter and water path. This transducer incorporates ALOKAs exclusive Hemispheric Sound Technology and ...
... Linear high frequency ... breast and superficial ... exclusive Hemispheric Sound ... technologies. This multi-frequency ...
... an excellent choice for a ... wide scan angle. With muliple ... designed for a wide view ... versatility of this transducer provides ...
Medicine Products: